Bladder Cancer Academy

2018 Bladder Cancer Academy

 

 

In our shared goal to ensure that our members receive optimal education on advances in bladder cancer treatment and to optimize patient management, we are pleased to announce the 2018 Bladder Cancer Academy (BCA) program. This program is co-sponsored by LUGPA and MedReviews, LLC, publishers of Reviews in Urology,® LUGPA’s Official Journal.

Presented at no cost to the attendee, BCA will cover round-trip air travel, two nights’ lodging, and on-site meals for the duration of the program.

BCA 2017 was highly successful, with more than 80 residents, fellows, and LUGPA members in attendance. Our outstanding faculty presented robust talks on the most relevant topics in our field, and we look forward to an even more successful program in 2018.

Bladder Cancer Academy convenes the evening of Thursday, March 1, 2018, and continues through early afternoon on Saturday, March 3, 2018, in St. Louis, Missouri. BCA will present, discuss, and debate all available preventive, diagnostic, therapeutic, and management options for bladder cancer in a highly interactive format. BCA’s program will include didactic lectures and case-based discussions.

Register Today

There are 50 seats available to LUGPA members, on a first-come, first-served basis. To register for BCA, the meeting, please visit www.bladdercanceracademy.com and click on “Attendee Registration.” Register as soon as possible, as space is limited.

Please review the agenda below. For questions or additional information, please contact Danielle Wagner, Associate Director of Program Management with MedReviews, via email at dwagner@medreviews.com.

 

Sincerely,

Arjun V. Balar, MD
Assistant Professor, Department of Medicine
Director, Genitourinary Medical Oncology Program
NYU Langone Medical Center
New York, NY

Herbert Lepor, MD
Professor, Department of Urology
Martin Spatz Chair, Department of Urology
Professor, Department of Biochemistry and
Molecular Pharmacology
NYU Langone Medical Center
New York, NY

Neal D. Shore, MD, FACS
President, LUGPA
Medical Director, Certified Physician Investigator
Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, SC


2018 Bladder Cancer Academy Agenda*

Thursday, March 1, 2018

6:30 p.m. – 8:30 p.m. Registration Desk Open
6:30 p.m. – 8:30 p.m. Welcome Dinner

Friday, March 2, 2018

7:50 a.m. Welcome and Introductions
8:00 a.m. – 8:50 a.m. Breakfast
8:55 a.m. Why LUGPA Embraces Managing Advanced Genitourinary Cancers Neal D. Shore, MD
Carolina Urologic Research Center
Atlantic Urology Clinics
9:35 a.m. Bladder Cancer Biomarkers: New and Old Michael Cookson, MD, MMHC
The University of Oklahoma Health Sciences Center
10:15 a.m. Quality Indicators and Enhanced Imaging in Cystoscope and TURBT Michael Cookson, MD, MMHC
The University of Oklahoma Health Sciences Center
10:55 a.m. – 11:20 a.m. Morning Break
11:25 a.m. Intravesical Therapy for High-risk Disease Colin P. Dinney, MD
The University of Texas
MD Anderson Cancer Center
12:05 p.m. Intravesical Therapy: When Bacillus Calmette-Guerin Fails Noah M. Hahn, MD
Johns Hopkins University School of Medicine
12:45 p.m. Case Presentation with Panel Discussion
1:15 p.m. – 2:15 p.m. Lunch
2:20 p.m. Bladder-sparing Strategies Jason A. Efstathiou, MD, DPhil
Harvard Medical School
Massachusetts General Hospital
3:00 p.m. Neoadjuvant and Adjuvant Chemotherapy: Bladder Cancer Matthew Galsky, MD
Mount Sinai School of Medicine
3:40 p.m. – 4:05 p.m. Afternoon Break
4:10 p.m. Immunotherapy of Advanced Bladder Cancer: The Next Frontier Jonathan E. Rosenberg, MD
Memorial Sloan Kettering Cancer Center
4:50 p.m. Case Presentation with Panel Discussion
5:20 p.m. Wrap-up Session
5:30 p.m. – 6:30 p.m. Networking Reception
6:30 p.m. – 7:30 p.m. Dinner

Saturday, March 3, 2018

7:00 a.m. Welcome Remarks
7:10 a.m. – 8:00 a.m. Breakfast
8:05 a.m. Managing Small Renal Masses Robert G. Uzzo, MD, FACS
Fox Chase Cancer Center
8:45 a.m. Surgical Management of Renal Cell Carcinoma Robert G. Uzzo, MD, FACS
Fox Chase Cancer Center
9:25 a.m. Systemic Renal Therapies: Targeted Molecules Anil Kapoor, MD
McMaster University
St. Joseph’s Hospital Hamilton
10:05 am – 10:30 am Morning Break
10:35 a.m. Systemic Therapies for Renal Cell Carcinoma: Combinations Beyond Single Agent PD-1 Hans Hammers, MD, PhD
UT Southwestern – Kidney Cancer Program
11:15 a.m. The Future of Genitourinary Cancers and Beyond Arjun V. Balar, MD
NYU Langone Medical Center
11:55 a.m. Closing Remarks
12:00 p.m. Departures


*Topics and speakers subject to change.


2017 Bladder Cancer Academy Presentations »